This article is authored by Ranjit Barshikar, CEO, QbD International, CGMP Consulting, United Nations Adviser.

The company revealed that its wholly owned subsidiary, Cana Laboratories, has entered into a ten-year contract manufacturing agreement with Provident Pharmaceuticals, a specialty pharmaceutical ...

Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organization (CDMO) and bioanalytical Contract ...

Akums Drugs and Pharmaceuticals reported a 15% increase in adjusted profit after tax, reaching Rs 66.3 crore for the quarter ...

With growing uncertainty in the trade environment, investors may delay new investments until policies become clearer.

President Paul Kagame on Thursday, February 6, met with Dr Sherine Helmy, the chief executive and chair of Egyptian drug company Pharco Pharmaceuticals, who is in Rwanda to explore investment ...

Registration is open for faculty to attend the Westwood Lecture Series on Feb. 19. Two leading Purdue researchers will discuss the university’s growing role in the next revolution of ...

In this Pharmaceutical Executive video interview, Edoardo Madussi, Head of Business Development, Intelligencia AI discusses ...

Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organization (CDMO) and bioanalytical ...

“A 25% tariff on Canada and Mexico threatens to upend the very supply chains that have made U.S. manufacturing more ...

President Donald Trump’s executive order imposing a 10% tariff on Chinese imports is likely to drive up the cost of generic ...